Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios

With high survival rates for chronic myeloid leukemia (CML) patients treated with BCR-ABL1 tyrosine kinase inhibitors (TKIs), emerging consequences, such as arterial ischemic events, require consideration when evaluating treatment options. Cardiovascular ischemic event incidence in clinical trials w...

Descripción completa

Detalles Bibliográficos
Autores principales: Saglio, Giuseppe, le Coutre, Philipp, Cortes, Jorge, Mayer, Jiří, Rowlings, Philip, Mahon, François-Xavier, Kroog, Glenn, Gooden, Kyna, Subar, Milayna, Shah, Neil P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486782/
https://www.ncbi.nlm.nih.gov/pubmed/28534184
http://dx.doi.org/10.1007/s00277-017-3012-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486782/
https://www.ncbi.nlm.nih.gov/pubmed/28534184
http://dx.doi.org/10.1007/s00277-017-3012-z

Ejemplares similares